Sol J. Barer - May 31, 2022 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Director
Signature
/s/ Andrew Pearce, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
May 31, 2022
Transactions value $
$226,154
Form type
4
Date filed
6/2/2022, 07:41 PM
Previous filing
May 18, 2022
Next filing
Jun 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Purchase $46.1K +20.7K +1.3% $2.22 1.62M Jun 2, 2022 Direct F1, F2
transaction NEXI Common Stock Purchase $94.2K +40K +2.57% $2.35 1.6M Jun 1, 2022 Direct F2, F3
transaction NEXI Common Stock Purchase $85.9K +39.3K +2.59% $2.19 1.56M May 31, 2022 Direct F2, F4
holding NEXI Common Stock 1.54M May 31, 2022 Held by B&S NexImmune Holdco LLC F5
holding NEXI Common Stock 347K May 31, 2022 Held by Joshua Barer F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.09 to $2.35, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 Excludes 175,012 shares of common stock underlying options that are currently exercisable.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.23 to $2.59, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.95 to $2.46, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F5 Mr. Sol Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein.
F6 Mr. Sol Barer is the father of Joshua Barer. Mr. Sol Barer disclaims beneficial ownership of the securities held by Joshua Barer except to the extent of his pecuniary interest therein.